Hepatitis screening for mongolians in France
Part of Cancer, Digestive system, Infections clinical trials.
This study offers free screening for hepatitis B, C, and delta to Mongolian people living in France. If you're found to have one of these infections, the study can help connect you to care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are of Mongolian origin.
- You are 15 years old or older.
- You live in France.
- If you are under 18, your parent or guardian must agree to your participation.
- You have not already been diagnosed with or treated for viral hepatitis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people in China who have hepatitis D, a liver infection. It aims to learn more about the disease and how it affects people, which may help improve future care.
This study builds a group of people to measure small hepatitis B “viral RNA” signals in the blood. The goal is to see if these measurements could help researchers find a functional cure and better understand who may respond over time.
This study tests a quick blood test to check migrants and refugees for hepatitis B and D. It aims to find infections early so people can get the right care.
This study offers free rapid screening for hepatitis B and C to adults in the Chinese community in Milan. It aims to understand how much people know about these infections and what risk factors they may have, so that better awareness and prevention can be promoted.
This study follows people with hepatocellular carcinoma (HCC), a type of liver cancer, to learn how it changes over time. It may help improve understanding of which patients benefit from different care approaches.
This study looks at new blood tests (biomarkers) to better understand chronic hepatitis B and how it affects treatment decisions. It may help doctors find better ways to manage your condition.
Hear when a new HEPATITIS C (HCV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.